EPHB2 Human

目录号: GP23408纯度: >98%
EPH Receptor B2 Human Recombinant

EPHB2 Human
规格价格库存数量操作
2μg¥840.00现货
1
10μg¥2,030.00现货
1
1mg¥72,800.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

EPHB2 Human Recombinant produced in Sf9 Baculovirus cellsis a single, glycosylated polypeptide chain containing 533 amino acids (19-543a.a)and having a molecular mass of 59.1kDa (Molecular size on SDS-PAGE will appearat approximately 50-70kDa). EPHB2 is fused to a 8 amino acid His-tag at C-terminus& purified by proprietary chromatographic techniques.

产品文档 Product Documents

Product Data

Purity
Greater than 90% as determined by SDS-PAGE.
Source
Sf9,Baculovirus cells.
Physical Appearance
Sterile Filtered colorless solution.
Shipping Condition
Shipped with Ice Packs.
Synonyms
EPHB2; CAPB; DRT; EK5; EPHT3; ERK; Hek5; PCBC; Tyro5; Developmentally-regulatedEph-related tyrosine kinase; ELK-related tyrosine kinase; EPH tyrosine kinase3; EPH-like kinase 5; hEK5; Renal carcinoma antigen NY-REN-47; Tyrosine-proteinkinase TYRO5; Tyrosine-protein kinase receptor EPH-3.
Amino Acid Sequence
VEETLMDSTT ATAELGWMVH PPSGWEEVSG YDENMNTIRT YQVCNVFESSQNNWLRTKFI RRRGAHRIHV EMKFSVRDCS SIPSVPGSCK ETFNLYYYEA DFDSATKTFP NWMENPWVKVDTIAADESFS QVDLGGRVMK INTEVRSFGP VSRSGFYLAF QDYGGCMSLI AVRVFYRKCP RIIQNGAIFQETLSGAESTS LVAARGSCIA NAEEVDVPIK LYCNGDGEWL VPIGRCMCKA GFEAVENGTV CRGCPSGTFKANQGDEACTH CPINSRTTSE GATNCVCRNG YYRADLDPLD MPCTTIPSAP QAVISSVNET SLMLEWTPPRDSGGREDLVY NIICKSCGSG RGACTRCGDN VQYAPRQLGL TEPRIYISDL LAHTQYTFEI QAVNGVTDQSPFSPQFASVN ITTNQAAPSA VSIMHQVSRT VDSITLSWSQ PDQPNGVILD YELQYYEKEL SEYNATAIKSPTNTVTVQGL KAGAIYVFQV RARTVAGYGR YSGKMYFQTM TEAEYQTSIQ EKLPLLEHHH HHH.
Stability
Store at 4°C if entire vial will be used within 2-4 weeks.Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
Formulation
EPHB2 protein solution (0.5mg/ml) containing PhosphateBuffered Saline (pH 7.4), 1mM DTT and 20% glycerol.